Arnuity Ellipta (Fluticasone Furoate) for asthma | MyAsthmaTeam

Connect with others who understand.

sign up Log in
About MyAsthmaTeam
Powered By

Arnuity Ellipta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat asthma in adults and children 12 years of age and older. Arnuity Ellipta is also referred to by its drug name, fluticasone furoate.

Arnuity Ellipta is a member of a class of drugs called corticosteroids, which are drugs that suppress the immune system and decrease inflammation in the body. Arnuity Ellipta is believed to work by decreasing inflammation in the lungs, which reduces the risk of bronchospasm (unwanted smooth muscle contraction of the airways).

How do I take it?
Prescribing information states that Arnuity Ellipta is administered once daily through an aerosol inhaler.

Arnuity Ellipta should be taken exactly as prescribed by a physician.

Side effects
The FDA-approved label for Arnuity Ellipta lists common side effects including upper respiratory tract infection, nasopharyngitis (common cold), headache, and bronchitis.

Rare but serious side effects listed for Arnuity Ellipta include fungal infections, worsening of asthma symptoms, hypercorticism (hormonal imbalance), decreased bone density, and glaucoma.

For more details about this treatment, visit:

Arnuity Ellipta — GSK

Fluticasone (Inhalation Route) — Mayo Clinic

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in